Stelo by Dexcom is a wearable glucose biosensor that brings continuous glucose monitoring into the consumer wellness space, ...
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors. The company said its Smart Basal ...
IEEE Spectrum on MSN
Why the most accurate glucose monitors are failing some users
In late November Abbott—one of Dexcom’s main competitors— recalled some of its CGMs due to inaccurate low glucose readings.
Some FreeStyle Libre 3 glucose sensors made by Abbott Diabetes Care may give incorrect low readings. The devices have been linked to potential deaths.
A new alert from the FDA warns that some sensors from Abbott may give incorrect blood sugar readings, which could lead to unsafe treatment decisions.
Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom (Nasdaq:DXCM) G7 15 ...
During your initial knee or hip replacement surgery, the prosthetic (artificial) components were either cemented (attached with bone cement) or hammered into the bone so they could eventually attach ...
Global healthcare giant Abbott is recalling faulty blood glucose sensors across multiple countries due to potentially ...
Synthesis of nanostructured cubic phase SnO 2 thin film and its trace-level sensing of CO gas This study presents a cubic phase SnO 2 thin film gas sensor with ultra-high CO sensitivity and 1 ppb ...
Some alternatives for hormone therapy (HT) may help manage menopause symptoms. Examples include diet and lifestyle changes, supplements, and exercise. Hormone therapy (HT) is generally an effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results